You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 2, February 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, SAN FRANCISCO, CALIF, MAY 21 TO MAY 24, 1989-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Indium 111 ZCE-025 Immunoscintigraphy in Occult Recurrent Colorectal Cancer With Elevated Carcinoembryonic Antigen Level

Ralph J. Doerr, MD; Hani Abdel-Nabi, MD, PhD; Bruce Merchant, MD, PhD

Arch Surg. 1990;125(2):226-229.


Abstract

• We investigated the utility of scanning with indium 111 labeled to monoclonal antibody in 13 patients after curative resection of colorectal cancer who had elevated carcinoembryonic antigen levels and negative results of clinical workup. Each patient received 1 mg of anti–carcinoembryonic antigen monoclonal antibody type ZCE 025 labeled with 5.5 mCi of111In, plus 9 to 39 mg of the same antibody unlabeled. Patients underwent scanning 3 to 7 days after infusion by planar and emission computed tomography. ZCE-025 monoclonal antibody imaging detected tumor recurrence or metastasis in 11 of 13 patients. In one patient the monoclonal antibody scan gave a true-negative result, and in one patient the monoclonal antibody scan failed to disclose a metachronous cecal primary. Tumor sites identified were the pelvis (2 patients), abdominal wall (2), retroperitoneum (1), lymph nodes (3), liver (2), bone (2), and lung (1). The accurate localization of colorectal carcinoma recurrences by means of111In ZCE-025 monoclonal antibody demonstrates the usefulness of this diagnostic agent in the setting of elevated carcinoembryonic antigen level and negative results of clinical and radiologic workup.

(Arch Surg. 1990;125:226-229)



Author Affiliations

From the Departments of Surgery (Dr Doerr) and Nuclear Medicine (Dr Abdel-Nabi), Veterans Administration Medical Center, Buffalo, NY, Buffalo General Hospital, and State University of New York at Buffalo; and Hybritech Inc, San Diego, Calif (Dr Merchant).


Footnotes

Accepted for publication October 14, 1989.

Read before the annual meeting of the Society of Surgical Oncology, San Francisco, Calif, May 24, 1989.

Reprint requests to Buffalo General Hospital, 100 High St, Buffalo, NY 14203 (Dr Doerr).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

99mTc--IMMU-4 Monoclonal Antibody Scan in Colorectal Cancer: A Prospective Study
Rodriguez-Bigas et al.
Arch Surg 1992;127:1321-1324.
ABSTRACT  

Detection of Occult Tumor Using Indium 111-Labeled Anticarcinoembryonic Antigen Antibodies
Halpern et al.
Arch Surg 1992;127:1094-1100.
ABSTRACT  

Radioimmunoguided Surgery Using Iodine 125 B72.3 in Patients With Colorectal Cancer
Cohen et al.
Arch Surg 1991;126:349-352.
ABSTRACT  

Detection of Primary Colorectal Cancer With Indium 111 Monoclonal Antibody B72.3
Doerr et al.
Arch Surg 1990;125:1601-1605.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.